Clinical Trial Update: Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 safety study of Paliperidone ER in patients with liver disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-09-20